Contents

Current Neuropharmacology, Volume 1 - Number 2

Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Schizophrenia and Depression: Findings in Humans, and Animal Models

, 1(2): 109 - 123

M. Fiore, F. Angelucci, L. Aloe, A. Iannitelli and J. Korf


DOI: 10.2174/1570159033477206




Pharmacologic Strategies for Suppression of Lipid Peroxidation in Neurodegeneration

, 1(2): 125 - 134

K. S. Montine, D. Milatovic, M. Doherty, J. D. Morrow and T. J. Montine


DOI: 10.2174/1570159033477170




Limiting Functional Deficiency Following Stroke: Exploiting Different Stem Cell Reservoirs

, 1(2): 135 - 152

David A. Stevens, Stephen D. Skaper and Andrew A. Parsons


DOI: 10.2174/1570159033477215




Serotonin Control of Dopaminergic Neurotransmission: Focus on 5-HT2 Receptors

, 1(2): 153 - 164

Vincenzo Di Matteo and Ennio Esposito


DOI: 10.2174/1570159033477189




Possible Role of the Extracellular Signal-Regulated Kinase (ERK) in Reward-Controlled Learning and Addiction

, 1(2): 165 - 174

Emmanuel Valjent, Denis Herve, Jocelyne Caboche and Jean-Antoine Girault


DOI: 10.2174/1570159033477198




Startle Response Modulation as a Behavioral Tool in Neuropharmacology

, 1(2): 175 - 185

M. Koch and M. Fendt


DOI: 10.2174/1570159033477161




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science